Elutia Inc (ELUT)

Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th

Jushi (OTCMKTS:JUSHF) vs. Elutia (NASDAQ:ELUT) Head-To-Head Survey

Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference

Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Elutia Inc. (ELUT) Q2 2026 Earnings Call Transcript

Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results

Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market

Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch